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Background
Recently, an alternative role of B cells has emerged. Regu-
latory B cells have been shown to down-regulate immune
responses in mice and humans. These cells control disease
progression in several models of human autoimmune
diseases, including a model of Multiple Sclerosis (MS).
Their regulatory function mostly relies on their capacity to
produce IL-10.
Objectives
Our aim was to explore the frequency, the phenotype and
the functional properties of regulatory B cells in MS
patients compared to Healthy Volunteers (HV).
Methods
All patients suffered from MS and had not received
immune drugs since at least 6 months. The frequency and
the phenotype of B cell subsets have been analysed using
different specific markers: CD19
+CD27
+ memory B cells,
CD19
+CD38
dimCD24
dim mature naïve B cells and CD19
+
CD24
highCD38
high transitional B cells. Their capacity to
secrete IL-10 was analysed in vitro 48 hours after stimula-
tion by CD40 ligand and CpG ODN.
Results
Thirty-eight MS patients (mean age: 41.55±12.8 yrs) and
21 HV (mean age: 35.4±13.4 yrs, NS) have been
included. The patients had different MS forms: Clini-
cally Isolated Syndrome (n=5), Relapsing-Remitting
(n=23), Secondary Progressive (n=4) and Primary Pro-
gressive (n=6).
No significant difference was found for the frequency
of the different B cell subsets in the different subgroups
of patients. Particularly, MS patients harbor the same
number (in frequency and absolute value) of CD19
+
CD24
highCD38
high transitional B cells. However, the fre-
quency of IL-10 secreting B cells was significantly
decreased in MS patients (0.9±0.5%, n=9) compared to
HV (2±0.95%, n=10, p<0.05, Mann Whitney test).
Discussion/perspectives
MS patients display the same frequency of CD19
+
CD24
highCD38
high transitional B cells, described as hav-
ing regulatory properties. Nevertheless, B cells of MS
patients present a significant decreased secretion of IL-
10, supporting a defect in the B cells regulatory property.
If confirmed, these results could have a considerable
impact for the development of new therapeutic strategies.
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